Data Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise Programme.
Nagaraj MalipatilHelene A FachimKirk SiddalsBethany GearyGwen WarkNick PorterSimon George AndersonRachelle P DonnMichelle HarvieAnthony D WhettonMartin J GibsonAdrian HealdPublished in: Journal of clinical medicine (2019)
We investigated biological determinants that would associate with the response to a diet and weight loss programme in impaired glucose regulation (IGR) people using sequential window acquisition of all theoretical fragment ion spectra (SWATH) mass spectrometry (MS), a data acquisition method which complement traditional mass spectrometry-based proteomics techniques. Ten women and 10 men with IGR underwent anthropometric measurements and fasting blood tests. SWATH MS was carried out with subsequent immunoassay of specific peptide levels. After a six-month intervention, 40% of participants lost 3% or more in weight, 45% of patients remained within 3% of their starting weight and 15% increased their weight by 3% or more. Hemoglobin A1c (HbA1C) level was reduced with weight loss with improvements in insulin sensitivity. SWATH MS on pre-intervention samples and subsequent principal component analysis identified a cluster of proteins associated with future weight loss, including insulin-like growth factor-II (IGF-II) and Vitamin D binding protein. Individuals who lost 3% in weight had significantly higher baseline IGF-II levels than those who did not lose weight. SWATH MS successfully discriminated between individuals who were more likely to lose weight and potentially improve their sensitivity to insulin. A higher IGF-II baseline was predictive of success with weight reduction, suggesting that biological determinants are important in response to weight loss and exercise regimes. This may permit better targeting of interventions to prevent diabetes in the future.
Keyphrases
- weight loss
- mass spectrometry
- bariatric surgery
- roux en y gastric bypass
- glycemic control
- liquid chromatography
- gastric bypass
- binding protein
- physical activity
- gas chromatography
- high performance liquid chromatography
- multiple sclerosis
- randomized controlled trial
- high resolution
- weight gain
- type diabetes
- ms ms
- blood glucose
- chronic kidney disease
- end stage renal disease
- cardiovascular disease
- current status
- study protocol
- newly diagnosed
- pregnant women
- growth hormone
- clinical trial
- metabolic syndrome
- adipose tissue
- molecular dynamics
- ejection fraction
- blood pressure
- label free
- patient reported outcomes